KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Interest & Investment Income (2016 - 2026)

Alnylam Pharmaceuticals filings provide 18 years of Interest & Investment Income readings, the most recent being $26.6 million for Q1 2026.

  • Quarterly Interest & Investment Income fell 7.24% to $26.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $109.4 million through Mar 2026, down 9.61% year-over-year, with the annual reading at $111.5 million for FY2025, 8.63% down from the prior year.
  • Interest & Investment Income hit $26.6 million in Q1 2026 for Alnylam Pharmaceuticals, roughly flat from $26.6 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $32.1 million in Q3 2024 and bottomed at $1.0 million in Q1 2022.
  • Average Interest & Investment Income over 5 years is $22.4 million, with a median of $26.6 million recorded in 2025.
  • The largest annual shift saw Interest & Investment Income skyrocketed 3375.56% in 2022 before it fell 14.15% in 2025.
  • Alnylam Pharmaceuticals' Interest & Investment Income stood at $14.1 million in 2022, then soared by 116.0% to $30.4 million in 2023, then grew by 2.02% to $31.0 million in 2024, then decreased by 14.15% to $26.6 million in 2025, then fell by 0.12% to $26.6 million in 2026.
  • Per Business Quant, the three most recent readings for ALNY's Interest & Investment Income are $26.6 million (Q1 2026), $26.6 million (Q4 2025), and $28.7 million (Q3 2025).